* Apollo Medical Holdings Inc AMEH.OQ AMEH.O is expected
to report results on May 5.
* Refinitiv's mean analyst estimate for Apollo Medical
Holdings
Inc is for earnings of 32 cents per share. For the same quarter
last year, the company reported earnings of 30 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Apollo
Medical
Holdings Inc is $49, above its last closing price of $37.85.
This summary was machine generated May 4 at 02:00 GMT. All
figures in US dollars unless otherwise stated